Melatonin Agb

Melatonin, the active ingredient in Melatonin Agb, is a melatonin receptor agonist presented as an oral dosage form for oral use. It helps regulate sleep onset and circadian rhythm in adults experiencing insomnia, jet lag, or related sleep disturbances.

GNH USA supplies Melatonin Agb as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin Agb acts on melatonin receptors to support normal sleep physiology. It is indicated for: - Insomnia: facilitates faster sleep onset in individuals with difficulty falling asleep. - Jet lag: assists in realigning the internal clock after rapid time‑zone travel. - Circadian rhythm sleep disorders: helps normalize disrupted sleep‑wake cycles such as shift‑work disorder.

Melatonin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness or daytime sleepiness - Headache - Dizziness - Nausea or mild gastrointestinal discomfort - Vivid dreams or nightmares - Mild fatigue

Serious or Rare Side Effects: - Allergic reaction (rash, itching, swelling) - Severe skin eruption or Stevens‑Johnson syndrome - Mood changes including depression or anxiety - Abnormal heart rhythm or palpitations - Hallucinations or confusion - Persistent severe daytime somnolence

When considering Melatonin Agb, several safety measures are recommended. - Assess sleep patterns: evaluate underlying causes before initiating therapy. - Driving and machinery: avoid operating heavy equipment until individual response is known. - Concomitant CNS depressants: use caution with benzodiazepines or alcohol. - Pregnancy and lactation: consult a healthcare professional before use. - Pediatric use: limit to supervised administration when indicated. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Melatonin can interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Warfarin or other anticoagulants: may increase bleeding risk. - Cyclosporine or other immunosuppressants: can alter melatonin metabolism. - Central nervous system depressants (e.g., benzodiazepines): may enhance sedation.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs) and other antidepressants. - Antihypertensive agents: possible additive blood‑pressure lowering. - Oral contraceptives: may affect hormone levels. - Caffeine or other stimulants: could counteract sleep‑promoting effect. - Alcohol: may increase drowsiness.